Vaccine Maker Beats Investor Suit Over Private Investment
By Emilie Ruscoe ( September 14, 2023, 9:43 PM EDT) -- Chinese vaccine maker Sinovac Biotech Ltd. no longer faces an investor's proposed class action alleging the company diluted public shareholders' equity with a private investment in public equity transaction after a Boston federal judge found that the claim was filed too late....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.